Compare AU

Compare QPON vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Australian Bank Senior Floating Rate Bond ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Australian Bank Senior Floating Rate Bond ETF (QPON) and the Global X S&P Biotech ETF (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

QPON

CURE

Popularity

Low

Low

Pearlers invested

11

82

Median incremental investment

$5,000.00

$619.50

Median investment frequency

Monthly

Monthly

Median total investment

$2,761.30

$1,323.41

Average age group

> 35

> 35


Key Summary

QPON

CURE

Strategy

QPON.AX was created on 2017-06-01 by BetaShares. The fund's investment portfolio concentrates primarily on high yield fixed income. QPON.AX aims to track the performance of an index (before fees and expenses) that measures the performance of a portfolio of some of the largest and most liquid senior floating rate bonds issued by Australian banks.

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

NATIONAL AUSTRALIA BANK LTD FRN MAR-29 (10.02 %)

WESTPAC BANKING CORP FRN MAY-29 (9.98 %)

WESTPAC BANKING CORP FRN JAN-29 (9.97 %)

Natera Inc (3.41 %)

Incyte Corp (2.94 %)

Gilead Sciences Inc (2.88 %)

Top 3 industries

Other (96.47 %)

Communication Services (3.53 %)

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.22 %

0.45 %


Key Summary

QPON

CURE

Issuer

BetaShares

Global X

Tracking index

Solactive Australian Bank Senior Floating Rate Bond Index - AUD

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.22 %

0.45 %

Price

$26.05

$49.94

Size

$1.551 billion

$38.065 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

2.63 %

4.24 %

Market

ASX

ASX

First listed date

06/06/2017

12/11/2018

Purchase fee

$6.50

$6.50


Community Stats

QPON

CURE

Popularity

Low

Low

Pearlers invested

11

82

Median incremental investment

$5,000.00

$619.50

Median investment frequency

Monthly

Monthly

Median total investment

$2,761.30

$1,323.41

Average age group

> 35

> 35


Pros and Cons

QPON

CURE

Pros

  • Lower management fee

  • Higher price growth

  • Higher exposure to US market

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Lower distribution yield

  • Higher management fee

  • Lower price growth

QPON

CURE

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home